Product correctly added to cart.

discount label
4-Methacryloyloxy-2,2,6,6-tetramethylpiperidine 1-oxyl free radical
View 3D

Biosynth logo

4-Methacryloyloxy-2,2,6,6-tetramethylpiperidine 1-oxyl free radical

CAS: 15051-46-4

Ref. 3D-FM75595

1gTo inquire
2gTo inquire
5gTo inquire
250mgTo inquire
500mgTo inquire
Estimated delivery in United States, on Friday 28 Jun 2024

Product Information

Name:
4-Methacryloyloxy-2,2,6,6-tetramethylpiperidine 1-oxyl free radical
Description:

4-Methacryloyloxy-2,2,6,6-tetramethylpiperidine 1-oxyl free radical is a reactive oxygen species that has been shown to be cytotoxic in human cancer cells. It is a monomer that can be polymerized with other monomers to form polymers. The polymer drug has a functional group that absorbs ultraviolet light and can be used for photodynamic therapy (PDT). 4-Methacryloyloxy-2,2,6,6-tetramethylpiperidine 1-oxyl free radical has conjugates with drugs such as doxorubicin and cisplatin. These conjugates have the ability to cross the cell membrane and target specific receptors on the cancer cell surface. This type of drug delivery system provides an increased therapeutic effect by reducing the dosage needed to kill cells. 4-Methacryloyloxy-2,2

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
240.32 g/mol
Formula:
C13H22NO3
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FM75595 4-Methacryloyloxy-2,2,6,6-tetramethylpiperidine 1-oxyl free radical

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".